InvestorsHub Logo
Followers 4
Posts 260
Boards Moderated 0
Alias Born 07/06/2010

Re: None

Thursday, 05/22/2014 10:27:36 AM

Thursday, May 22, 2014 10:27:36 AM

Post# of 9947
The following posted on TOS (Think or Swim).

NEW YORK , May 22, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Provectus Biopharmaceuticals, Inc. ("Provectus" or the "Company")(NYSE: PVCT).  Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237.
The investigation concerns whether Provectus and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. 

Suberizedwrx
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PVCT News